SOURCE: TraceLink Inc.

TraceLink Inc.

September 12, 2016 09:00 ET

Intalere Chooses TraceLink to Offer DSCSA Compliance Solutions to Over 90,000 Members of Hospital & Healthcare Provider Network

TraceLink Now Has Access to Over 80% of Entire U.S. Hospital Market Through Its GPO Partnerships

NORTH READING, MA--(Marketwired - Sep 12, 2016) - TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced a national group purchasing contract with Intalere, an industry leader in delivering optimal cost, quality and clinical outcomes for its members. Under this agreement, TraceLink's market-leading Product Track solution will be offered at pre-negotiated contract terms and pricing for approximately 90,000 healthcare providers within the Intalere member network, providing them with an affordable path to comply with the U.S. Drug Supply Chain Security Act (DSCSA).

This partnership further validates TraceLink's position as the leading solution provider for DSCSA compliance and adds to TraceLink's growing network of group purchasing organization (GPO) alliances, which now covers more than 80 percent of the entire U.S. hospital market.

With the TraceLink Product Track solution, Intalere members will also join the TraceLink network of more than 240,000 global healthcare entities working together to secure the pharmaceutical supply chain, and a growing community of hospitals and pharmacy leaders that use Product Track at over 4,000 dispensing locations throughout the United States. By accessing TraceLink's easy-to-use, proven solution, hospitals, pharmacies and healthcare providers are able to eliminate the burden of compliance paperwork, giving them more time to provide critical care to patients.

"We are excited to partner with Intalere, one of the most innovative healthcare service organizations, and offer TraceLink's proven solution to their extensive member network of hospitals and healthcare providers," said Shabbir Dahod, president and CEO of TraceLink. "Our expanding partnerships in the GPO market now give the majority of U.S. hospitals access to TraceLink's Product Track during a critical time as they prepare to comply with the next phase of DSCSA."

To learn more about how TraceLink can help protect pharmacy operations, easily help them meet DSCSA requirements and enable a direct connection with over 1,000 suppliers, ranging from the "Big Three" wholesale distributors and the largest pharmaceutical manufacturers, visit http://www.tracelink.com/dispensers/intalere.

About Intalere
Intalere's mission focuses on improving the operational health of America's healthcare providers by designing tailored, smart solutions that deliver optimal cost, quality and clinical outcomes. We strive to be the essential partner for operational excellence in healthcare through customized solutions that address customers' individual needs. We assist our customers in managing their entire spend, providing innovative technologies, products and services, and leveraging the best practices of a provider-led model. As Intalere draws on the power of our owner Intermountain Healthcare's nationally-recognized supply chain expertise and leadership in technology, process improvement, and evidence-based clinical and business best practices, we are uniquely positioned to be the innovation leader in the healthcare industry. Visit www.intalere.com to learn more.

About TraceLink
TraceLink is the world's largest track and trace network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses, including 16 of the top-20 global pharmaceutical companies, trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 293 in 2015), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.

TraceLink is funded by FirstMark Capital, Volition Capital and F-Prime Capital.

Contact Information

  • Contacts

    Aimee Genzler
    Director, Corporate Communications
    Email Contact
    978.396.6150